| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 24,782 | $17.87 | $442,792.39 | -6.8% | |
| Nov 2, 2020 | Crowley John F67 | Chairman &CEO | Sale+OE | 33,875 | $17.87 | $605,271.73 | -3.9% | |
| Nov 2, 2020 | Whitman Burke W50 | Director | Buy | 1,500 | $18.01 | $27,015.00 | +4.2% | |
| Oct 9, 2020 | Do Hung | Chief Science Officer | Sale+OE | 193,700 | $15.03 | $2,911,272.26 | -27.1% | |
| Oct 1, 2020 | Quimi Daphne58 | Chief Financial Officer | Sale+OE | 5,000 | $14.02 | $70,099.00 | -2.4% | |
| Oct 1, 2020 | Crowley John F67 | Chairman &CEO | Sale+OE | 29,900 | $14.02 | $419,105.31 | -3.4% | |
| Oct 1, 2020 | Whitman Burke W50 | Director | Buy | 1,500 | $14.28 | $21,412.95 | +4.4% | |
| Sep 30, 2020 | Barth Jay | Chief Medical Officer | Sale+OE | 4,064 | $14.51 | $58,951.16 | -2.4% | |
| Sep 28, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 24,782 | $13.89 | $344,204.63 | -6.8% | |
| Sep 1, 2020 | Whitman Burke W50 | Director | Buy | 1,500 | $14.62 | $21,930.00 | +4.6% |